CXCL13 and neoplasm: Conversely, it induces low expression of Th2 cytokine and chemokine CXCL13, decreases myeloid-derived suppressor cells (MDSCs), Tregs, and M2 macrophages in the tumor area, inhibits tumor metastasis to the lungs, and significantly inhibits tumor growth when combined with docetaxel-loaded PEG-modified liposomes [538].